As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...

2 Dividend Stocks to Buy Hand Over Fist in November was originally published by The Motley Fool Their recent issues are ...

Amgen refutes in a press release that its trial obesity drug, MariTide, may cause bone loss density. Amgen's stock has risen 4.6% this year against a decrease of 3.8% for the pharmaceuticals industry.

Citigroupa expanded its biotech coverage on Wednesday, adding five more stocks to the roster including Amgen (NASDAQ:AMGN), ...

As it becomes clearer that Indian markets have to deal with domestic slowdown and increased uncertainty under Donald Trump’s ...

One of the best ways to build wealth is with dividend stocks – especially if they’re attached to solid companies with a ...

Oil and gas major Shell on Tuesday won an appeal against a landmark ruling that required it to accelerate carbon reduction ...

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company’s principal products include Enbrel to treat ... while those in the top 20% receive A grades, which ...

Citi has started coverage of Gilead Sciences (NASDAQ:GILD) and Vertex Pharmaceuticals (NASDAQ:VRTX) at buy saying the former will benefit from short-term growth of Biktarvy (bictegravir, emtricitabine ...

This piece will outline the best practices for designing CI/CD architectures and ... However, this flexibility is essential ...

Register now to see our 7 Best Stocks for the Next 30 Days report - free today ... million of AstraZeneca’s share of gross ...